Vitisin B inhibits influenza A virus replication by multi-targeting neuraminidase and virus-induced oxidative stress

The development of drug-resistant influenza and new pathogenic virus strains underscores the need for antiviral therapeutics. Currently, neuraminidase (NA) inhibitors are commonly used antiviral drugs approved by the US Food and Drug Administration (FDA) for the prevention and treatment of influenza...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Eun-Bin, Li, Wei, Kim, Young Soo, Kim, Buyun, Chung, Hwan-Suck, Go, Younghoon, Ko, Hyun-Jeong, Song, Jae-Hyoung, Kim, Young Ho, Choi, Chun Whan, Choi, Jang-Gi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939323/
https://www.ncbi.nlm.nih.gov/pubmed/36815046
http://dx.doi.org/10.1016/j.apsb.2022.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939323/
https://www.ncbi.nlm.nih.gov/pubmed/36815046
http://dx.doi.org/10.1016/j.apsb.2022.07.001

Ejemplares similares